Legislature(2015 - 2016)BUTROVICH 205
03/30/2016 01:30 PM Senate HEALTH & SOCIAL SERVICES
Note: the audio ![]()
and video ![]()
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| SB113 | |
| SB156 | |
| SB179 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| += | SB 113 | TELECONFERENCED | |
| += | SB 156 | TELECONFERENCED | |
| *+ | SB 179 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
SB 113-NEW DRUGS FOR THE TERMINALLY ILL
1:33:42 PM
CHAIR STEDMAN announced the consideration of SB 113.
1:34:33 PM
SENATOR BILL WIELECHOWSKI, Alaska State Legislature, as sponsor,
introduced SB 113. He termed SB 113 the "Right to Try" bill. It
would create a legal climate in which terminally ill patients
who have exhausted all FDA-approved treatment options may work
with their doctors and drug manufacturers to access
investigational treatments that have passed Phase I of the FDA
approval process but are not yet widely available. A similar
bill has been passed in 25 states. It is estimated that over a
million Americans die from terminal illness. Currently, only
about 3 percent are accepted into clinical trials and have
access to these drugs.
SENATOR STOLTZE thanked the sponsor for answering all his
questions.
1:36:07 PM
SENATOR ELLIS moved to report SB 113, labeled 29-LS0783\H,
from committee with individual recommendations and attached zero
fiscal note. There being no objection, the motion carried.